It has also been shown that intratumoral injection of OBP-702 exhibits antitumor effect in subcutaneous and orthotopic tumor models with human pancreatic cancer cells harboring in-frame BRAF deletion [16]. This evidence concerns the gene BRAF and neoplasm.